Compton Capital Management Inc Ri buys $2,829,084 stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : Compton Capital Management Inc Ri scooped up 180 additional shares in Thermo Fisher Scientific during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 17,967 shares of Thermo Fisher Scientific which is valued at $2,829,084.Thermo Fisher Scientific makes up approximately 1.51% of Compton Capital Management Inc Ri’s portfolio.

Other Hedge Funds, Including , Bank Of The West reduced its stake in TMO by selling 9,120 shares or 55.94% in the most recent quarter. The Hedge Fund company now holds 7,182 shares of TMO which is valued at $1,131,237. Thermo Fisher Scientific makes up approx 0.15% of Bank Of The West’s portfolio.Flossbach Von Storch Ag reduced its stake in TMO by selling 20,960 shares or 36.13% in the most recent quarter. The Hedge Fund company now holds 37,060 shares of TMO which is valued at $5,886,610. Thermo Fisher Scientific makes up approx 0.10% of Flossbach Von Storch Ag’s portfolio.Investment Partners Ltd Oh Adv reduced its stake in TMO by selling 1,887 shares or 54.36% in the most recent quarter. The Hedge Fund company now holds 1,584 shares of TMO which is valued at $245,203. Thermo Fisher Scientific makes up approx 0.24% of Investment Partners Ltd Oh Adv’s portfolio.

Thermo Fisher Scientific opened for trading at $155.69 and hit $156.46 on the upside on Monday, eventually ending the session at $155.97, with a gain of 0.31% or 0.48 points. The heightened volatility saw the trading volume jump to 9,59,130 shares. Company has a market cap of $61,493 M.

On the company’s financial health, Thermo Fisher Scientific reported $2.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $2.01. The company had revenue of $4535.20 million for the quarter, compared to analysts expectations of $4493.28 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS.

Investors should note that on Jul 7, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Sep 13, 2016 as the ex-dividend date and fixed the record date on Sep 15, 2016. The payable date has been fixed on Oct 17, 2016.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 27, 2016 to “Buy”, Firm has raised the Price Target to $ 170 from a previous price target of $166 .Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.